Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.4K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

657
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
657
Initiation of Translation02:33

Initiation of Translation

38.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.9K
Initiation of Translation02:33

Initiation of Translation

8.1K
8.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

612
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Design and analysis of a cantilever-based MEMS switch with dielectric thin film material coatings for enhanced electrostatic actuation.

Scientific reports·2026
Same author

Trends of severe human metapneumovirus infections in India.

BMC infectious diseases·2026
Same author

IoT-integrated rGO@Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> MXene-based ammonia sensors: a DFT mechanistic insight for real-time monitoring.

Nanoscale·2026
Same author

Mercapto-methylimidazole molecular memristors for high-performance resistive switching and artificial synaptic emulation.

Nanoscale·2026
Same author

Interfacial Salt Engineering with Alkali and Ammonium Additives for Stable Pure-Blue Perovskite Light-Emitting Diodes and Micropatterned Displays.

ACS nano·2026
Same author

Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

Biomedicines·2026

関連する実験動画

Updated: Jan 29, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K

Widaplik：高血圧初期治療のための固定用量三重配合剤

Mahnoor Niaz1, Rimsha Ahmad2, Saifullah Khan1

  • 1From the Department of Internal Medicine, MedStar Health, Georgetown University School of Medicine, Washington, DC.

Cardiology in review
|January 28, 2026
PubMed
まとめ

新しい三重療法薬であるWidaplikは、高血圧の初期治療として効果的です。血圧管理を簡略化し、管理率の向上と心血管リスクの低減を目指します。

キーワード:
Widaplik血圧療法高血圧

さらに関連する動画

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.3K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.9K

関連する実験動画

Last Updated: Jan 29, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.3K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.9K

科学分野:

  • 循環器病学
  • 薬理学
  • 高血圧管理

背景:

  • 高血圧は、世界的に心血管疾患の主要な修正可能な危険因子です。
  • 利用可能な治療法にもかかわらず、血圧管理の不十分さが続いています。
  • 現在のガイドラインでは、高血圧管理における早期の併用療法を推奨しています。

研究 の 目的:

  • 高血圧における低用量三重療法の薬理学的根拠をレビューすること。
  • 新規固定用量三重配合剤（テルミサルタン、アムロジピン、インダパミド）の臨床試験エビデンスを検討すること。
  • 高血圧管理の改善と心血管リスクの低減におけるこの新しい療法の役割を議論すること。

主な方法:

  • 作用機序の相補性を考慮した薬理学的根拠のレビュー。
  • 重要な第3相臨床試験データの検討。
  • 安全性、忍容性、および実用的な考慮事項の分析。

主要な成果:

  • 三重療法は、迅速かつ持続的な血圧低下を示しました。
  • 二重療法と比較して、より高い高血圧管理率が観察されました。
  • 臨床試験では、良好な忍容性が報告されました。

結論:

  • 固定用量三重配合剤であるWidaplikは、複数の薬剤を必要とする可能性が高い高血圧患者の初期治療として初めて承認されました。
  • この単純化されたアプローチは、血圧管理の改善のための主要なメカニズムをターゲットとしています。
  • 長期的な心血管アウトカムに関するさらなる研究が必要です。